Prosecutors accuse the Fort Worth cardiologist of joining an alleged nationwide billing and certification operation that used student-athlete cardiovascular testing to obtain payments from commercial insurers, Medicaid, veterans’ healthcare, and federal employee benefit plans.
WASHINGTON, DC — Cardiologist Jason Finkelstein faces one federal conspiracy count alleging healthcare fraud and wire fraud objectives, alongside three substantive healthcare-fraud counts arising from an alleged nationwide cardiovascular testing operation that billed public programs and commercial insurers.
Federal prosecutors contend that Finkelstein supplied the medical authority, multistate licensing, corporate billing vehicles, and electronic certifications needed to transform campus screening events into diagnostic claims, although he has pleaded not guilty and remains presumed innocent.
The Justice Department’s current case summary identifies the prosecution as United States against Jason Finkelstein, docket number 26-cr-80123, pending before Judge Aileen Cannon at the Southern District of Florida’s West Palm Beach courthouse.
The case concerns approximately $89 million in allegedly false claims and more than $13.1 million in payments, but those figures describe the government’s accusations rather than adjudicated losses, proven proceeds, or final restitution obligations.
One Conspiracy Count Alleges Two Criminal Objectives
Count One charges conspiracy under Title 18, United States Code, Section 1349, alleging that Finkelstein knowingly agreed with two unidentified co-conspirators and others to pursue both healthcare fraud and wire fraud through a coordinated billing operation.
The healthcare-fraud objective centers upon alleged efforts to obtain money controlled by health benefit programs through materially false representations connected with medical services, including disputed diagnoses, professional involvement, service locations, medical necessity, and completed interpretations.
The wire-fraud objective focuses upon an alleged plan to obtain money through deception while using interstate electronic communications, including claim transmissions routed through medical billing systems and other digital exchanges that moved information beyond Florida.
Although headlines may compress the allegations into healthcare-fraud and wire-fraud charges, the indictment does not list a separate substantive wire-fraud count; instead, it places the wire theory within the broader conspiracy alleged in Count One.
That distinction matters because conspiracy examines whether a defendant knowingly joined an unlawful agreement, while a substantive offense examines whether the defendant executed or attempted a particular fraudulent transaction satisfying the elements identified by Congress.
Three Healthcare-Fraud Counts Identify Particular Claims
Counts Two through Four charge substantive healthcare fraud under Title 18, United States Code, Sections 1347 and 2, connecting the government’s wider narrative with three specified claims that prosecutors characterize as executions or attempted executions of the scheme.
Two counts concern abdominal aorta ultrasound claims associated with patients identified by initials, dated October 4, 2023, and January 25, 2024, with each disputed claim listing approximately $150 as the amount billed through medical software.
The fourth count concerns an October 2024 claim for electrocardiogram, echocardiogram, and vascular ultrasound services involving a student athlete identified by the initials KF, with the indictment listing approximately $975 as the billed amount.
Those comparatively modest claim amounts do not reduce the seriousness of the case, because prosecutors may use individual transactions to prove execution while presenting the alleged $89 million pattern as evidence explaining knowledge, method, repetition, and purpose.
Defense counsel can require the government to prove each charged claim separately, including who prepared it, what records supported it, which representation was allegedly false, whether that representation affected payment, and what Finkelstein personally knew.
Interstate Billing Supplies the Alleged Wire Component
Wire fraud does not require a dramatic telephone call or secret message, because routine electronic claim transmissions can supply the interstate communication element when prosecutors prove they were used to carry out a knowingly deceptive plan.
The indictment alleges that the Florida testing business used a medical billing software company located outside Florida, while claims and related documentation were electronically transmitted to private insurers and government-connected healthcare programs serving beneficiaries across numerous states.
Prosecutors will likely trace claim files, submission timestamps, clearinghouse routes, payer responses, electronic appeals, and banking transfers to show how the alleged plan depended upon predictable interstate communications rather than isolated local medical encounters.
Finkelstein’s defense may examine whether he sent any disputed transmission, reasonably foresaw the use of electronic billing, understood the claim information selected by administrative personnel, or participated in an agreement encompassing the alleged interstate deception.
Because Count One alleges a conspiracy with both healthcare-fraud and wire-fraud objectives, jurors will need precise instructions explaining the charged agreement, the required intent, and the factual findings necessary before any verdict can be returned.
Government and Commercial Programs Allegedly Paid Claims
The indictment identifies a mixed group of alleged payers, including commercial health plans, the Federal Employees Health Benefits Program, the Veterans Health Administration, and Medicaid, creating both private financial exposure and direct public-interest consequences.
Commercial insurers named in the charging document include Aetna, Blue Cross and Blue Shield of Texas, Capital District, Cigna, UnitedHealth Group, and the University of Pittsburgh Medical Center Health Plan, each operating under distinct coverage arrangements.
The federal employee program supplies or supports coverage for eligible federal workers, retirees, spouses, and dependents, while the Veterans Health Administration serves qualifying veterans and Medicaid combines federal and state resources for eligible lower-income recipients.
Traditional Medicare is not identified among the benefit programs allegedly billed in this indictment, an important distinction because national healthcare-fraud announcements often encourage audiences to describe every government-connected prosecution inaccurately as a Medicare case.
The government says these payers reimbursed more than $13.1 million into bank accounts associated with Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA, two Texas professional associations allegedly owned and controlled by Finkelstein.
Coverage Turned on Medical Necessity
Diagnostic cardiovascular procedures may be reimbursable when symptoms, medical history, examinations, or other individualized evidence establish a clinical need, while generalized screening of an asymptomatic population may fall outside coverage except under limited circumstances.
Prosecutors allege that the student athletes received broadly offered screening services, yet claims presented those encounters as medically necessary diagnostic care supported by qualifying conditions, physician involvement, and coverage representations that did not reflect reality.
The indictment says false diagnoses, including hypertension or elevated blood pressure, were assigned to completed medical questionnaires, thereby making students appear eligible for testing that insurers otherwise would not have reimbursed as routine campus screening.
That allegation will require patient-level proof because an inaccurate diagnosis may result from clerical error, coding interpretation, incomplete information, or negligent documentation, whereas criminal fraud requires evidence supporting knowing and willful deception rather than mistake alone.
Insurer guidelines, student questionnaires, blood-pressure readings, examination records, coding histories, claim edits, and communications among clinical and billing personnel could reveal whether disputed diagnoses reflected genuine concerns or were inserted primarily to obtain payment.
Corporate Structure Connected Campuses with Payers
Finkelstein allegedly served as medical director of an unnamed Florida cardiovascular company, while also owning Cardiovascular Testing Services and Cardiovascular Healthcare Associates, which prosecutors say submitted claims generated by testing performed on campuses throughout the United States.
Corporate entities are common and lawful in healthcare, yet prosecutors contend these particular relationships allowed an out-of-state campus operation to place Finkelstein’s credentials, provider information, and Texas associations behind large volumes of diagnostic claims.
The government further alleges participants formed additional companies to circumvent payer efforts against fraudulent billing and conceal one co-conspirator’s involvement, accusations that may become significant evidence of consciousness, coordination, deliberate continuation, and shared criminal purpose.
Defense lawyers can distinguish legitimate restructuring, payer contracting, delegated billing, and professional ownership from concealment, insisting that corporate complexity becomes incriminating only when admissible evidence establishes its knowing use to advance material deception against identified payers.
Campus Marketing Allegedly Generated Patient Volume
Employees of the Florida company allegedly approached college athletic trainers with messages emphasizing that cardiovascular testing could identify dangerous conditions, while presenting the service as carrying no direct cost for participating student athletes.
At some schools, prosecutors say athletes were told testing was mandatory for team participation, a representation that could turn a commercial medical offer into an apparent institutional requirement and put substantial pressure on students concerned about eligibility.
The indictment also alleges two co-conspirators offered checks, wire transfers, and gift cards to athletic trainers or other referral sources, introducing alleged financial inducements into relationships students could reasonably interpret as independent health guidance.
Associated Press coverage placed the Finkelstein prosecution within a nationwide enforcement announcement involving hundreds of defendants, while emphasizing allegations that unnecessary athlete testing was approved as normal without meaningful physician review of underlying results.
Prosecutors must still connect disputed marketing and referral conduct to Finkelstein’s knowledge, because statements or inducements attributed to unnamed associates do not automatically establish that he authorized, understood, or joined every operational decision.
A Standardized Testing Panel Became a Billing Pattern
Traveling sonographers allegedly administered substantially the same six cardiovascular tests to almost every athlete, including electrocardiograms, echocardiograms, and vascular ultrasound imaging, despite differences in symptoms, histories, risks, insurance coverage, and individualized clinical circumstances.
The government portrays that uniformity as evidence of a reimbursement-driven protocol, arguing that a physician never conducted the preliminary examination needed to determine why every test was appropriate for every student receiving the recurring package.
Some sonographers allegedly lacked credentials required for their work, raising additional questions about image acquisition, payer requirements, state rules, supervision, and the dependability of preliminary information reaching the physician identified as the reviewing provider.
Standardization and remote testing are not inherently fraudulent, however, so the prosecution must prove that the repeated panel was medically unnecessary, ineligible, or falsely represented within charged claims rather than merely unconventional or aggressively administered.
Electronic Certifications Allegedly Completed the Claims
Using an electronic platform, Finkelstein allegedly signed cardiovascular results as normal within a few seconds of accessing the files, even when the studies included numerous images and preliminary information that demanded careful professional interpretation.
Those approvals carried dual significance within the government’s theory, because they communicated reassuring clinical conclusions to students while also supporting claims representing that a qualified physician had reviewed and interpreted the diagnostic services billed.
Prosecutors may compare access logs, file volumes, preliminary notations, signature times, report templates, and subsequent claims to argue that meaningful physician review was physically implausible across a repeated national pattern rather than occasionally rushed.
The defense can test whether the platform recorded only a final administrative action, whether images were reviewed earlier or elsewhere, whether preliminary readers assisted, whether accounts were shared, and whether exported logs preserve the entire workflow.
Digital evidence often appears exact while remaining context-dependent, making expert testimony important when jurors assess what a timestamp establishes about access, attention, interpretation, authorship, system behavior, earlier work, and the defendant’s subjective knowledge.
One Student Athlete’s Death Intensifies the Case
The indictment describes approximately 63 images from one athlete’s October 2024 cardiovascular testing, some containing unconfirmed preliminary references to possible right atrial and right ventricular hypertrophy before Finkelstein allegedly signed the collection as normal.
Prosecutors say he approved those images approximately eleven seconds after accessing them, and the athlete later died from sudden cardiac arrest approximately twenty-four days after the disputed certification, giving the billing prosecution exceptional human gravity.
The government further alleges Finkelstein continued certifying other athletes’ studies without meaningful review after learning about the death and concerns raised by the student’s mother, which prosecutors may offer as evidence concerning knowledge and intent.
The defense retains the right to challenge the preliminary notations, digital timing, cause of death, connection between any imaging finding and later collapse, professional responsibilities, and whether disputed conduct demonstrates fraud rather than negligence.
An adverse outcome cannot itself prove criminal liability, but the episode may help jurors evaluate whether claimed failures of review were material to students, insurers, and benefit programs relying upon accurate medical services.
The Financial Allegations Require Careful Definitions
Prosecutors say participants submitted more than $89 million in allegedly false claims and obtained more than $13.1 million in payments, while Finkelstein allegedly received approximately $1.1 million through checks and wires connected with reimbursements during the charged period.
Those amounts describe different concepts because submitted charges, insurer payments, personal compensation, alleged proceeds, intended loss, actual loss, restitution, and forfeiture are calculated under different legal standards and may change substantially through litigation and expert analysis.
The indictment seeks a forfeiture money judgment of approximately $13,146,886, representing funds prosecutors characterize as derived from the alleged offenses, together with substitute property if directly traceable assets become unavailable under applicable forfeiture procedures.
A forfeiture allegation remains contingent upon conviction and proof, however, meaning the requested judgment is neither a current debt nor a judicial determination that every payment lacked value or flowed personally to Finkelstein.
Financial experts may separate legitimate testing from challenged services, examine insurer-specific policies, trace bank deposits, analyze ownership interests, reconcile claim reversals, and determine whether the government’s aggregate figures properly reflect each charged participant’s conduct.
Investigators Can Reconstruct the Alleged Agreement
The prosecution will likely combine corporate records, emails, text messages, student questionnaires, school agreements, referral payments, credential files, diagnostic images, electronic audit trails, payer policies, appeals, bank records, software evidence, and witness testimony.
No single category necessarily proves conspiracy, but converging evidence may show whether participants shared an unlawful purpose, understood how false information entered claims, benefited from reimbursements, and adjusted operations when insurers raised concerns.
An August 2022 text exchange described in the indictment may receive special attention because Finkelstein allegedly stated that he did not read abdominal aorta ultrasounds, yet related claims purportedly continued until approximately January 2024.
Prosecutors can characterize that communication as notice of a disconnect between billed interpretations and actual review, while defense counsel can seek surrounding messages, workplace definitions, reader assignments, and later records supplying a different context.
Electronic appeals submitted after claim denials may also reveal knowledge because the government alleges false supporting documentation was used, although appealing a denial remains ordinary healthcare administration unless the material supplied was knowingly deceptive.
The Defense Can Challenge Attribution and Intent
Finkelstein’s professional role and ownership interests may give prosecutors a route to responsibility, but neither status alone proves he knew how marketers, sonographers, coders, billers, software vendors, or managers handled individual transactions.
Defense lawyers may argue that employees made unauthorized decisions, software populated inaccurate fields, clinical conclusions were debatable, payer requirements varied, administrative mistakes accumulated, or electronic records omitted legitimate review completed outside the captured interval.
They may also challenge whether particular misstatements were material, whether insurers would have paid accurately documented services, whether Finkelstein joined any agreement, and whether compensation represented ordinary professional income rather than criminal proceeds.
The government can answer by emphasizing repetition, communications, ownership, payments, implausibly fast approvals, continued conduct after warnings, false service locations, standardized diagnoses, and alleged efforts to circumvent payer controls through strategically formed additional companies.
Jurors must ultimately distinguish poor medicine, negligent supervision, contractual disputes, and coding errors from intentional fraud, because federal criminal liability requires proof beyond reasonable doubt rather than suspicion generated by troubling outcomes or unusual business practices.
National Enforcement Provides Context but Not Proof
The indictment was announced during a broad federal healthcare-fraud crackdown, giving prosecutors a national platform for allegations involving public money, private insurance, professional credentials, digital billing, and patients who relied upon medical assurances.
Large enforcement announcements can highlight recurring vulnerabilities, yet each defendant must receive an individualized adjudication because aggregate dollar figures, accusations against unrelated providers, and official rhetoric cannot substitute for evidence proving Finkelstein’s charged conduct.
This case differs from prosecutions focused exclusively upon nonexistent equipment or services, since prosecutors allege real testing occurred while medical necessity, professional credentials, physician ordering, interpretation, claim descriptions, service locations, and clinical value were materially misrepresented.
That combination makes the litigation important for insurers and healthcare organizations because it tests where inefficient care, inadequate review, aggressive screening, and inaccurate billing cross the boundary into a knowingly coordinated federal fraud scheme.
Schools and Insurers Face Broader Oversight Questions
Colleges considering outside medical vendors should verify who orders services, why each procedure is necessary, who acquires and interprets results, how insurers are billed, whether referrals generate compensation, and how abnormalities receive follow-up.
Payers can examine repeated test bundles, identical diagnosis patterns, implausible service locations, concentrated campus dates, high-volume reviewing physicians, rapid signatures, and appeals inconsistent with underlying records without treating analytical anomalies as automatic proof.
Athletes should receive clear information explaining whether testing is optional, which entities may receive claims, what diagnoses will enter their records, who reviews images, and which clinician bears responsibility for communicating significant findings.
Institutional trust becomes especially vulnerable when a vendor combines lifesaving language with no-cost promises, because students may assume that administrators have independently validated clinical standards, billing practices, professional credentials, privacy protections, and emergency procedures.
Reputation Management Must Follow the Record
Healthcare organizations confronting comparable allegations need coordinated communication that addresses patients, employees, schools, insurers, regulators, and reporters without disclosing protected records, influencing witnesses, contradicting counsel, minimizing safety concerns, or presenting accusations as proven findings.
Amicus International Consulting’s crisis public relations guidance emphasizes structured assessment and consistent messaging, principles that can support accurate stakeholder communication throughout intense public scrutiny while legal counsel manages evidentiary, confidentiality, and procedural obligations.
Its framework for rebuilding a damaged public reputation similarly underscores sustained, verifiable communication, although ethical reputation work cannot erase authentic court records, manufacture exoneration, suppress legitimate reporting, or replace accountability after adjudicated misconduct.
Responsible coverage should repeatedly attribute allegations, distinguish billed amounts from payments, avoid calling this a Medicare prosecution, explain the precise federal count structure, and recognize prominently in every developing report that Finkelstein has pleaded not guilty.
Current Schedule Extends the Unresolved Period
The Justice Department currently lists a September 16, 2026, status conference, a March 30, 2027, calendar call, and an April 5, 2027, trial before Judge Cannon in federal court in West Palm Beach.
That timetable gives both sides substantial time to review nationwide claims data, medical records, electronic systems, diagnostic images, payer policies, company communications, financial transfers, campus evidence, and expert opinions addressing both medicine and billing.
Court dates may change through later orders, while motions could narrow evidence, reshape legal theories, resolve discovery disputes, or produce another lawful disposition before jurors hear testimony concerning the government’s extensive accusations and disputed evidence.
The Presumption of Innocence Remains Controlling
The prosecution’s theory presents Finkelstein as a physician whose credentials and certifications allegedly connected campus testing with interstate claims paid by private insurers and government-backed programs, creating a unified clinical and financial deception.
The defense can seek to dismantle that account by separating medical interpretation from billing administration, challenging technical evidence, contesting attribution, identifying legitimate services, and demanding transaction-specific proof of knowledge, agreement, materiality, and intent.
Until a jury returns a verdict or the case ends through another lawful resolution, Jason Finkelstein remains presumed innocent, while the indictment represents allegations that federal prosecutors must establish through admissible evidence beyond a reasonable doubt.
Be First to Comment